WaveMan · Form 4
Dolan Thomas Charles insider trades
> Search tickers & screens ⌘K
LIVE

Dolan Thomas Charles insider trades

Dolan Thomas Charles has filed 24 Form 4s with the SEC that we hold, for Sphere Entertainment Co. (SPHR) (Director), Madison Square Garden Entertainment Corp. (MSGE) (Director), AMC Global Media Inc. (AMCX) (Director) and Madison Square Garden Sports Corp. (MSGS) (Director), among 5 companies in all. Across all of them we count 1 purchase worth $10.0M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 322,580 shares of Madison Square Garden Entertainment Corp. worth $10.0M, dated 2023-06-27. The first filing on our record is dated 2021-07-13 and the latest 2026-06-18.

Sphere Entertainment Co. (SPHR)

Director · 7 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Madison Square Garden Entertainment Corp. (MSGE)

Director · 6 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-06-27P, purchase reported on Form 4322,580$10.0M2023-06-27

AMC Global Media Inc. (AMCX)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Madison Square Garden Sports Corp. (MSGS)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MSGN

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 933029) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms